GLAXO - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.8
Show all parameters (20 more)
🧾 Trade Setup
I'd suggest a buy entry at 2,840 ₹, utilizing a tight stop-loss order at 2,830 ₹ to protect against a pullback. For profit-taking, set a target price at 2,885 ₹, or re-evaluate if the stock breaches the 2,900 mark; this trade is predicated on continued momentum and short-term bullish sentiment. Overall, proceed with caution given the valuation concerns.
✅ Positive
The stock is exhibiting strong momentum with a significant increase in volume today, reaching 1.3 million shares – substantially above the average weekly volume of 73,487. The recent price action has pushed it above the 200-day moving average, suggesting a bullish trend could continue for now.
⚠️ Limitation
Despite the strong volume and positive momentum, the high P/E ratio of 45.6 compared to the industry PE of 34.8 indicates potential overvaluation, particularly given the slight decline in PAT Qtr. Furthermore, the PEG ratio of 2.91 confirms this concern – a high value suggests that the stock’s price is not justified by its expected growth rate.
📉 Company Negative News
Both Univest reports cite a "Hold" rating for Glaxosmithkline Pharmaceuticals Ltd., reflecting concerns about valuation despite the recent share price increase, suggesting potential resistance to further gains today.
🏭 Industry
The pharmaceutical sector is currently experiencing moderate volatility with several major players exhibiting similar P/E ratios, indicating broader investor sentiment in the space remains cautiously optimistic regarding growth prospects.